ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 91 filers reported holding ENDOCYTE INC in Q3 2016. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $105,000 | +8.2% | 5,870 | -16.7% | 0.00% | – |
Q2 2018 | $97,000 | +49.2% | 7,050 | 0.0% | 0.00% | – |
Q1 2018 | $65,000 | +18.2% | 7,050 | -45.3% | 0.00% | – |
Q4 2017 | $55,000 | +103.7% | 12,882 | -30.8% | 0.00% | – |
Q3 2017 | $27,000 | -81.6% | 18,610 | -81.0% | 0.00% | – |
Q2 2017 | $147,000 | -53.5% | 98,140 | -20.2% | 0.00% | – |
Q1 2017 | $316,000 | -8.7% | 122,961 | -9.5% | 0.00% | – |
Q4 2016 | $346,000 | -21.4% | 135,846 | -4.4% | 0.00% | – |
Q3 2016 | $440,000 | -9.5% | 142,146 | -6.0% | 0.00% | – |
Q2 2016 | $486,000 | +3.6% | 151,165 | -0.0% | 0.00% | – |
Q1 2016 | $469,000 | -27.8% | 151,212 | -6.6% | 0.00% | – |
Q4 2015 | $650,000 | -25.2% | 161,931 | -14.7% | 0.00% | -100.0% |
Q3 2015 | $869,000 | -13.1% | 189,822 | -1.5% | 0.00% | 0.0% |
Q2 2015 | $1,000,000 | +97.2% | 192,646 | +138.0% | 0.00% | – |
Q1 2015 | $507,000 | -10.9% | 80,944 | -10.5% | 0.00% | – |
Q4 2014 | $569,000 | +2.3% | 90,437 | -1.1% | 0.00% | – |
Q3 2014 | $556,000 | -6.6% | 91,402 | +1.2% | 0.00% | – |
Q2 2014 | $595,000 | -75.5% | 90,317 | -11.4% | 0.00% | -100.0% |
Q1 2014 | $2,426,000 | +182.4% | 101,885 | +26.7% | 0.00% | +100.0% |
Q4 2013 | $859,000 | +39.4% | 80,426 | +73.9% | 0.00% | – |
Q3 2013 | $616,000 | +14.3% | 46,260 | +12.6% | 0.00% | – |
Q2 2013 | $539,000 | – | 41,072 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|